Analyst consensus rating
Journey Medical Analyst Rating: Strong Buy
Direct answer
Journey Medical's consensus rating is Strong Buy.
4 analysts are included in the current consensus when a coverage count is available.
The same consensus reports an average price target of $13.75.
Forecast evidence checked October 17, 2026.
Get free Journey Medical email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $4.97
- Average price target
- $13.75
- High price target
- $15.00
- Low price target
- $13.00
- Low target gap
- +161.8%
- Target upside
- +176.9%
- High target gap
- +202.1%
- Target range width
- 40.3%
- Consensus rating
- Strong Buy
- Analysts
- 4
- Evidence date
- October 17, 2026
- Valid through
- October 24, 2026
Explore related company data
Read the frequently asked questions.
What is the analyst consensus rating for Journey Medical?
Journey Medical has a verified Strong Buy consensus. The same dataset has an average price target of $13.75.
How far are Journey Medical's low and high targets from the recorded price?
The low target implies +161.8%, while the high target implies +202.1%.
How many analysts are included in Journey Medical's consensus?
The verified consensus includes 4 analysts.
How is Journey Medical's target upside or downside calculated?
The average target of $13.75 is divided by the recorded price of $4.97, then one is subtracted to produce +176.9%. This does not guarantee a future return.
When was Journey Medical's analyst forecast verified?
The data was verified on 2026-10-17. The dataset is valid through 2026-10-24.